Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News Coronavirus

Data reveal increase in antibodies from Johnson & Johnson vaccine boosters

Chidinma Anyalewechi by Chidinma Anyalewechi
August 27, 2021
in Coronavirus
Data reveal increase in antibodies from Johnson & Johnson vaccine boosters
Share on FacebookShare on TwitterShare on Linkedin

The Johnson & Johnson (J&J) company has said that a booster shot of its COVID-19 vaccine sharply increases levels of antibodies, according to interim data from two early-stage trials.

According to the company, a second dose of the vaccine resulted in binding antibody levels that are nine times higher than the levels, 28 days after people received their first dose.

The data revealed that the binding antibodies attach to the virus but do not destroy it or prevent infection but instead, alert the immune system of its presence so white blood cells can be sent to destroy it.

RelatedPosts

FG says Nigeria gathering vaccine producers to develop technology in case of future outbreaks

You can now go to United States without COVID-19 tests

Prior to now, there has previously been no evidence about the effect of the booster dose of the J&J vaccine.

The new information comes as several countries have begun offering booster doses of other vaccines to individuals considered as vulnerable, including the immunocompromised, as the Delta variant has continued to spread and even vaccinated people have caught the virus.

US Centers for Disease Control and Prevention (CDC) advisers, in particular, have been waiting for word on how to advise immunocompromised individuals who received the J&J vaccine.

According to Johnson & Johnson, studies showed significant increases in binding antibody responses in participants aged 18-55 and in those 65 years and older who received a lower booster dose.

The results were released before long-awaited results from J&J’s large, two-dose vaccine trial. A spokesman said those results will be available in the coming weeks. The head of research and development at J&J’s Janssen pharma division, Mathai Mammen, stated in a statement that, “With these new data, we also see that a booster dose of the Johnson & Johnson COVID-19 vaccine further increases antibody responses among study participants who had previously received our vaccine.”

In July, J&J published data in the New England Journal of Medicine that showed neutralising antibodies generated by its vaccine remained stable eight months after immunisation with a single dose.

Related

Tags: Covid-19 vaccineDisease Control and Prevention (CDC)Johnson & Johnson (J&J)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Mega Millions
Hot forex
Cornerstone
Polaris Bank
Access Bank
Bankers Committee
First bank


FCMB




    Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

    Recent News

    • Top 10 stockbroking firms in Nigeria by value in the first half of 2022
    • CAF to launch $200 million African Super League in August 2023
    • Despite market sell-off, these crypto’s have positive YTD return

    Follow us on social media:

    Recent News

    THIS WEEK: Double wins for Airtel, Nigerian Stocks approach 50,000, US economy contracts

    Top 10 stockbroking firms in Nigeria by value in the first half of 2022

    July 4, 2022

    CAF to launch $200 million African Super League in August 2023

    July 4, 2022
    • ABOUT US
    • CONTACT US
    • PRODUCTS
    • ANDROID APP
    • iOS APP
    • DISCLAIMER
    • CAREERS
    • PRIVACY POLICY

    © 2022 Nairametrics

    No Result
    View All Result
    • Home
    • Exclusives
      • Financial Analysis
      • Corporate Stories
      • Interviews
      • Investigations
      • Metrics
    • Markets
      • Cryptos
      • Commodities
      • Equities
        • Dividends
        • Stock Market
      • Fixed Income
      • Market Views
      • Securities
    • Industries
      • Company News
      • Consumer Goods
      • Content Partners
      • Corporate deals
      • Corporate Press Releases
      • Energy
      • Entertainment
      • Financial Services
      • Hospitality & Travel
      • Manufacturing
      • Real Estate and Construction
      • Tech News
    • Economy
      • Get Data
      • Macro-Economic News
      • Research Analysis
    • Business News
    • Financial Literacy
      • Career tips
      • Personal Finance
    • Lifestyle
      • Billionaire Watch
      • Profiles
    • Opinions
      • Blurb
      • Op-Eds

    © 2022 Nairametrics

    Social Media Auto Publish Powered By : XYZScripts.com